Delivery Order SPE2D021DA002-SPE2D326F1681
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded a $3,833.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, was made without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $2,613.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract was awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order was issued under DMS...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,045.50 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies (two-pack). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price procurement with no set-aside designation, demonstrating the company's competitive capability in unrestricted federal contracting. The delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of epinephrine 0.3 mg auto-injector pens (two-pack). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order carries a firm...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price delivery order, valued at $2,590.25, was awarded on November 26, 2025, with completion scheduled for November 28, 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,045.50. Issued on December 1, 2025, with an ultimate completion date of December 2, 2025, this firm fixed-price delivery order represents a routine procurement under the company's existing pharmaceutical supply contract....
- The U.S. Defense Logistics Agency Medical Supply Chain issued a firm fixed-price delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is expected to be completed by September 5, 2025, and represents performance at the vendor's Park...
- The Defense Logistics Agency awarded a delivery order valued at $2,202.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector (2 units). The award, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. Performance will be executed in Conshohocken, Pennsylvania....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of epinephrine auto-injectors. This firm fixed-price delivery order, valued at $2,326.24, was issued on March 4, 2025, with an ultimate completion date of March 14, 2025. The award carries no set-aside designation, and performance will take place at the contractor's Park Ridge...
- The Defense Logistics Agency, through its Medical Supply Chain function, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Epinephrine 0.3 mg auto-injector two-packs. The contract, valued at $1,742.50 with an ultimate completion date of August 25, 2025, was awarded on August 20, 2025, on a firm fixed-price basis with no set-aside designation. The vendor will perform deliveries from its Park Ridge, Illinois facility. This...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F1681Delivery Order
The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,279.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector sets. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value and extends through December 31, 2036. DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the Department of Defense's medical supply chain, maintaining consistent contract performance across multiple therapeutic categories and product lines. The PPV-G GEN V program represents a comprehensive $30.3 billion acquisition strategy designed to enable the Defense Logistics Agency to issue delivery orders for an extensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, vaccines, and medical consumables to support military healthcare facilities worldwide. This particular delivery order for epinephrine auto-injectors exemplifies the contractor's role in supplying emergency medications essential to Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/25/25 |